Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

CNTO-1275 modulates CLA via IL-12 in the treatment of psoriasis

Dec. 15, 2005

ISA-247 shows long-term safety in patients with moderate to severe psoriasis

Dec. 13, 2005

Novel agents for alopecia, psoriasis claimed in recent patents

Dec. 9, 2005

Vitae begins phase II study for VTP-201227 in psoriasis

Dec. 1, 2005

AAGP protects skin cells from ultra violet-C radiation

Dec. 1, 2005

PEP-005 Topical produces statistically significant complete clearance of AK skin lesions in phase II

Dec. 1, 2005

Topical treatment with the novel thiazolidinedione BP-1107 reduces epidermal hyperplasia

Dec. 1, 2005

Leo Pharma and Foamix to develop medicated foams for psoriasis

Nov. 30, 2005

New synthetic retinoic acid agonist reduces wrinkles without irritating skin

Nov. 28, 2005

Epitan inlicenses Vaniqa for Australia

Nov. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...